AstraZeneca Looks To China For Growth – But CEO Says Spinoff Not Happening Forbes – Markets

AstraZeneca Looks To China For Growth – But CEO Says Spinoff Not Happening Forbes – Markets

AstraZeneca is the largest foreign owned pharmaceutical company in China based on revenue, and they’re continuing to increase investment in the country

Read More